( ISSN 2277 - 9809 (online) ISSN 2348 - 9359 (Print) ) New DOI : 10.32804/IRJMSH

Impact Factor* - 6.2311


**Need Help in Content editing, Data Analysis.

Research Gateway

Adv For Editing Content

   No of Download : 97    Submit Your Rating     Cite This   Download        Certificate

CORPORATE SOCIAL RESPONSIBILITY AND SUSTAINABLE DEVELOPMENT IN PHARMACEUTICAL INDUSTRIES IN INDIA: A CASE STUDY

    2 Author(s):  PRIYA GUPTA,SAMIR GHOSH

Vol -  13, Issue- 12 ,         Page(s) : 318 - 323  (2022 ) DOI : https://doi.org/10.32804/IRJMSH

Abstract

The pharmaceutical industry currently accounts for 1.72 percent of the country's GDP. Sustainable development and creating value for the stakeholders are two missions that will drive the company to realize its corporate responsibility vision which will be built on four strategic pillars of the corporate responsibility framework – ‘safe & quality products at affordable cost’, ‘valuing our people’, ‘helping the environment & sustainability’ and ‘empowering our communities’.

Lee, Matthew, Kohler, Jillian Benchmarking and Transparency: Incentives for the Pharmaceutical Industry’s Corporate Social Responsibility. Journal of Business Ethics. 2010. Volume, DOI 10.1007/s10551-010-0444-y P.643 
Leisinger, Klaus. Corporate Responsibilities for Access to Medicines. Journal of Business Ethics. 2008. DOI 10.1007/s10551-008-9944-4 P.1 
Leisinger, Klaus. Corporate Responsibilities for Access to Medicines. Journal of Business Ethics. 2008. Volume, DOI 10.1007/s10551-008-9944-4 P.5 

*Contents are provided by Authors of articles. Please contact us if you having any query.






Bank Details